Go to the profile of Gary Allenby

Gary Allenby

Chief Scientific Officer, Aurelia Bioscience

About Gary Allenby

Ph.D. in Reproductive Toxicology, post-doc at Hoffmann La Roche in U.S.A. working on retinoid (Vitamin A) biology, returned to UK to work at Glaxo Wellcome developing cell-based assay development for screening purposes then AstraZeneca. In 2011 I was one of the founding entrepreneurs of Aurelia Bioscience, a CRO in the UK. We develop bioassays for clients to test compounds and biologics.

Contact Gary Allenby

Phone Number
+44 115 837 0503

More About Gary Allenby

  • CRO
Areas of Interest
  • Drug discovery